Patent details
300895
Product Name:
Rolapitant, desgewenst in de vorm van een farmaceutisch aanvaardbaar zout, met inbegrip van rolapitant hydrochloridemonohydraat
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300895
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1463716
Status:
Invalid because the basic patent has lapsed before the expiration date or has been revoked
Application number:
300895
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)
Marketing Authorization
Marketing Authorization Number:
EU/1/17/1180/001
Marketing Authorization Type:
EEA
Marketing Authorization Date:
24/04/2017
Marketing Authorization Country:
European Patent Office (EPO) (EP)
Dates
Filing date:
11/10/2017
First Marketing Authorization date:
24/04/2017
Grant date:
21/11/2017
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
20/10/2017
SPC/SPC Extension Expiration Date:
16/12/2027
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
20/10/2017
Name:
Tesaro, Inc.
Address:
1000 Winter St. North, MA 02451, Waltham, United States of America (US)
Agent
Name:
ir. H.A. Witmans c.s.
From:
11/10/2017
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
32/20
Publication date:
05/08/2020
Description:
Lapse or annulment
2
Bulletin Heading:
SPC
Journal edition number:
47/17
Publication date:
22/11/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
Bulletin Heading:
SPC
Journal edition number:
43/17
Publication date:
25/10/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Annual Fee
Annual Fee(s) Due Date:
31/12/2022
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date
Document type
Document Description
Number of pages
File Type
21/11/2017
SPC Documents
Certificate SPC
1
PDF
/3/9/0/6/0/0800206093/docs/300895_0_supplprotectioncertificate20171122100149575.pdf
21/11/2017
Outgoing Correspondence
Decision grant
1
PDF
/3/9/0/6/0/0800206093/docs/300895_8_outgoingcorrespondence20171122100149532.pdf
20/10/2017
Outgoing Correspondence
Confirmation receipt request
1
PDF
/3/9/0/6/0/0800206093/docs/300895_6_169490l174.pdf
11/10/2017
SPC Documents
Summary of the characteristics of the product
16
PDF
/3/9/0/6/0/0800206093/docs/300895_1_supplprotectioncertificate20171020090452108.pdf
11/10/2017
Application Form
First filed application form
3
PDF
/3/9/0/6/0/0800206093/docs/300895_2_applicationform20171020090451545.pdf
11/10/2017
SPC Documents
Marketing Authorization SPC
3
PDF
/3/9/0/6/0/0800206093/docs/300895_3_supplprotectioncertificate20171020090451755.pdf
11/10/2017
SPC Documents
Annex SPC
2
PDF
/3/9/0/6/0/0800206093/docs/300895_4_supplprotectioncertificate20171020090452247.pdf
11/10/2017
SPC Documents
Annex SPC
1
PDF
/3/9/0/6/0/0800206093/docs/300895_5_supplprotectioncertificate20210112011254174.pdf
11/10/2017
SPC Documents
Annex SPC
12
PDF
/3/9/0/6/0/0800206093/docs/300895_7_supplprotectioncertificate20171020090452402.pdf